Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Search Inside the pdf :

Glenmark Pharmaceuticals Ltd.

27 May 2025

2085.20

-1.10%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our letter dated 19th May, 2025 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings call held on Monday, May 26, 2025 for the fourth quarter ended March 31, 2025 has been uploaded on the Company''s website.

pdf

Glenmark Pharmaceuticals Ltd.

26 May 2025

2085.20

-1.10%

Earnings Call

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q4 FY 2024-25 earnings call held on 26th May, 2025 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

26 May 2025

2085.20

-1.10%

Glenmark Pharmaceuticals Results Earnings Call for Q4FY25 & Full Year

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.

audio

Glenmark Pharmaceuticals Ltd.

19 Feb 2025, 05:01PM

2085.20

-1.10%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Further to our letter dated 5th February, 2025 and pursuant to Regulation 30(6) read with Part A of Schedule III of SEBI (LODR), Regulations 2015, the transcript of the Earnings Call held on Monday, 17th February, 2025 for the third quarter ended December 31, 2024 has been uploaded on the Company''s website.

pdf

Glenmark Pharmaceuticals Ltd.

17 Feb 2025

2085.20

-1.10%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q3 FY 2024 - 25 Earnings Call held on 17th February, 2025 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

17 Feb 2025

2085.20

-1.10%

Glenmark Pharmaceuticals Results Earnings Call for Q3FY25

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.

Glenmark Pharmaceuticals Ltd.

21 Nov 2024

2085.20

-1.10%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of earnings call held on Monday, November 18, 2024 for the second quarter ended September 30, 2024 has been uploaded on Company''s website.

pdf

Glenmark Pharmaceuticals Ltd.

18 Nov 2024, 03:57PM

2085.20

-1.10%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the Regulation 30 and 46 read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we hereby confirm that we have uploaded audio recording of Q2 FY 2024 - 25 Earnings Call held on 18th November, 2024 on the website of the Company.

pdf

Glenmark Pharmaceuticals Ltd.

18 Nov 2024, 11:19AM

2085.20

-1.10%

Glenmark Pharmaceuticals Results Earnings Call for Q2FY25

Conference Call with Glenmark Pharmaceuticals Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.

Glenmark Pharmaceuticals Ltd.

20 Aug 2024

2085.20

-1.10%

Earnings Call

GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of earnings call held on Friday, August 16, 2024 for the first quarter ended June 30, 2024 has been uploaded on Company''s website.

pdf

Glenmark Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts